WO2004075942A1 - Method for the production of a suture reinforcement device - Google Patents

Method for the production of a suture reinforcement device Download PDF

Info

Publication number
WO2004075942A1
WO2004075942A1 PCT/FR2004/000160 FR2004000160W WO2004075942A1 WO 2004075942 A1 WO2004075942 A1 WO 2004075942A1 FR 2004000160 W FR2004000160 W FR 2004000160W WO 2004075942 A1 WO2004075942 A1 WO 2004075942A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
alginate
sheet
web
propylene glycol
Prior art date
Application number
PCT/FR2004/000160
Other languages
French (fr)
Inventor
Philippe Maingault
Original Assignee
Les Laboratoires Brothier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Brothier filed Critical Les Laboratoires Brothier
Publication of WO2004075942A1 publication Critical patent/WO2004075942A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/042Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068Surgical staplers, e.g. containing multiple staples or clamps
    • A61B17/072Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
    • A61B17/07292Reinforcements for staple line, e.g. pledgets

Definitions

  • the invention relates to the manufacture of a device used in surgery to strengthen the tissue areas during the placement of sutures made using staples or threads.
  • Patent application WO 99/55397 describes such a device or implant consisting of a textile sheet made from polyuronic acid or its salts.
  • the sheet may be of the woven, knitted or non-woven type, and the material particularly targeted is calcium alginate in the form of fibers or filaments.
  • the tablecloth can be used in flat splints. However, when it is used with a suture forceps, it preferably has the shape of a sheath which is fitted onto each pin of the latter.
  • the sheet of calcium alginate is impregnated with an alginate ester.
  • the coating is carried out in particular by soaking in a solution of sodium alginate ester at 3%, in particular propylene glycol alginate (PGA).
  • PGA propylene glycol alginate
  • Patent FR 2 789 885 describes a method of manufacturing a device intended to be fitted onto a spindle of a suture forceps.
  • a linear knitting loom is supplied with calcium alginate fibers.
  • We make a tabular knit in jersey whose diameter is substantially equal to that of the pin of the pliers.
  • the excess solution is removed and then dried with hot air, at 45 ° C. example given Finally we remove the device.
  • the alginate forming the textile web and the coating material, has interesting properties for sutures. It facilitates tissue healing. It gives the devices good mechanical resistance to strengthen the sutured wound during healing. On contact with blood, the coating alginate softens and becomes charged with biological fluid. It spreads over the entire surface of the fabric and envelops the staples, sealing all the web gaps and perforations, thus ensuring air and liquid tightness.
  • the present invention relates to a method of manufacturing a suture reinforcement device overcoming the incompatibility between the materials and leading to a product whose mechanical strength is sufficient to absorb, without yielding, the forces exerted by the staples or the threads. sutures.
  • the present invention also relates to the manufacture of a suture reinforcement which when brought into contact with a physiological liquid leads to a progressive dissolution of the coating.
  • the process according to the invention in which a textile web is produced from a calcium alginate, the web is coated with propylene glycol alginate in solution and the web is dried, is characterized in that said calcium alginate is of the guluronic type and the said propylene glycol alginate with which the web is coated has an esterification rate greater than 70% and preferably greater than 80%.
  • the coating is carried out by immersion, the immersion time of the sheet in the solution is less than 1 minute and the concentration of propylene glycol alginate in said solution is between 3 and 10%.
  • the concentration is determined so as to obtain a viscosity of the solution of between 8000 and 16000 ctp at 25 ° C.
  • the PGA coating layer gradually dissolves. It causes immediate adhesion to tissue. It induces a rapid sealing, in a few minutes, of the sheet by embedding the latter in a viscous layer of PGA. It causes a gradual and slow gelation, within a few days, of the water table. It thus facilitates the biodegradation of the water table, in a few months, at the implanted site.
  • the propylene glycol alginate solution (PGA) is emulsified beforehand.
  • the quantity of alginate deposited is reduced by air bubbles, and the bubbles slow down the penetration of the PGA into the sheet.
  • the sheet After coating, the sheet is drained and then dried with dry air at a temperature of 40 ° C. to 50 ° C., preferably 45 ° C., until a residual water content of less than 15% is obtained after drying.
  • Calcium alginate wire was previously produced in a conventional manner.
  • the wire title is chosen between 100 and 160 dTex.
  • the alginate is of the guluronic type.
  • the molar ratio between the two basic monomers: mannuronic acid M and guluronic acid G is chosen such that M / G ⁇ 1 # We knit with the thread on a circular knitter.
  • the mesh is a locked jersey of the “locked stitches” type with a gauge 32. It allows to obtain a knitted fabric with a tight mesh when the thread is fine, as here.
  • the diameter of the sheath is determined according to the type of clamp for which it is intended.
  • the sheath is put on, unrolled and cut on a form of non-stick material such as Teflon (registered trademark) with a polygonal section corresponding to that of the branches of the clamp.
  • a form of non-stick material such as Teflon (registered trademark) with a polygonal section corresponding to that of the branches of the clamp.
  • the whole is immersed in a PGA solution for a determined time, less than one minute.
  • the rate of esterification of the selected PGA is high. 11 is preferably greater than or equal to 80%.
  • the product sold under the name Protanal ester L-25 A H by the company FMC was selected. The product is obtained from seaweed. Its degree of esterification is between 80 and 90%.
  • the concentration of the PGA solution is between 3 and 10% depending on the viscosity which is itself between 8000 and 16000 ctp at 25 ° C.
  • a 5% solution was prepared here with a viscosity of about 12,000 ctp.
  • an emulsion of the solution was formed by mechanically incorporating air into an emulsifier.
  • the foam has the advantage by its bubbles of reducing the contact zones with the material constituting the knitted fabric and of slowing down the penetration of the solution within the knitted fabric.
  • the knitted fabric after coating, has an internal part of calcium alginate and an external part of PGA.
  • the sheath is then dried. This must satisfy a speed constraint to reduce the destructuring effect of PGA on knitting. In fact, once dry, the PGA is compatible with calcium alginate. The temperature should also be moderate to avoid destroying the PGA. If the solution is in the form of a foam, vacuum drying should be avoided.
  • Drying was carried out by sweeping dry air at 45 ° C.
  • a drying cycle in a 0.5 m 3 enclosure makes it possible to process 7000 cm 2 to 14000 cm 2 , depending on the formats. 14000 cm 2 containing 2.3 liters of water, it takes 34.5 minutes to bring the sample to a residual water content of less than 15% in the finished product.
  • the dryer used has a capacity of 21 of water evaporated in 30 'at a temperature of 45 ° C.
  • the product once dried, is demolded. To make this operation easier, the form is subjected to a thermal shock, for 10 minutes at -25 ° C. for example.
  • the treated sheaths are cut to the length of use adapted to the pins of the suture forceps.
  • the products were reinforcements based on mannuronic (M) and guluronic (G) calcium alginate impregnated with PGA. Samples were immersed simultaneously in beakers containing 40ml of deionized water and in beakers containing 20ml of 0.9% NaCl * The appearance of the samples was observed at different contact times and evaluated on a scale of 0 to 4, 0 being the weak resistance and 4 being the strong resistance.
  • the reinforcement based on alginate type M / G ⁇ 1 has greater resistance to destructuring over time than the reinforcement based on calcium alginate type M G> 1.

Abstract

The invention relates to a method for the production of a suture reinforcement device wherein a textile web is manufactured from calcium alginate, the textile web is impregnated with propylene glycol alginate solution and the web is dried. The method is characterized in that said calcium alginate is of the guluronic variety and the glycol propylene alginate which is used to impregnate the web has an esterification rate of more than 70 %, preferably more than 80 %. The immersion time of the web in said solution is short less than 1 minute.

Description

Procédé de fabrication d'un dispositif de renfort de sutureMethod for manufacturing a suture reinforcement device
L'invention se rapporte à la fabrication d'un dispositif utilisé en chirurgie pour renforcer les zones tissulaires lors de la mise en place de sutures réalisées à l'aide d'agrafes ou de fils.The invention relates to the manufacture of a device used in surgery to strengthen the tissue areas during the placement of sutures made using staples or threads.
La demande de brevet WO 99/55397 décrit un tel dispositif ou implant constitué d'une nappe textile réalisée à base d'acide polyuronique ou de ses sels. La nappe peut être du type tissé, tricoté ou non-tissé, et le matériau particulièrement visé est l'alginate de calcium sous la forme de fibres ou de filaments. La nappe peut être utilisée en attelles planes. Cependant lorsqu'on l'utilise avec une pince à suture, elle a de préférence la forme d'une gaine que l'on emmanche sur chaque broche de celle-ci.Patent application WO 99/55397 describes such a device or implant consisting of a textile sheet made from polyuronic acid or its salts. The sheet may be of the woven, knitted or non-woven type, and the material particularly targeted is calcium alginate in the form of fibers or filaments. The tablecloth can be used in flat splints. However, when it is used with a suture forceps, it preferably has the shape of a sheath which is fitted onto each pin of the latter.
Lorsque l'étanchéité gazeuse et sanguine est requise, comme, par exemple, dans le cas de sutures réalisées sur des tissus pulmonaires, la nappe d'alginate de calcium est imprégnée d'un ester d'alginate.When gas and blood tightness is required, such as, for example, in the case of sutures made on pulmonary tissues, the sheet of calcium alginate is impregnated with an alginate ester.
On procède à l'enduction notamment par trempage dans une solution d'ester d'alginate de sodium à 3 %, en particulier l'alginate de propylène glycol (PGA).The coating is carried out in particular by soaking in a solution of sodium alginate ester at 3%, in particular propylene glycol alginate (PGA).
Le brevet FR 2 789 885 décrit un procédé de fabrication d'un dispositif destiné à être emmanché sur une broche d'une pince de suture.Patent FR 2 789 885 describes a method of manufacturing a device intended to be fitted onto a spindle of a suture forceps.
On alimente en fibres d'alginate de calcium un métier à tricoter linéaire. On réalise un tricot "tabulaire en jersey dont le diamètre est sensiblement égal à celui de la broche de la pince. On enfile le tricot sur une forme dont le matériau est anti-adhésif, Té lon (marque déposée) par exemple. On plonge la forme habillée du tricot dans un bain contenant une solution aqueuse à 3% d'ester d'alginate afin d'en enduire le tricot. On élimine le surplus de solution puis on sèche à l'air chaud, à 45°C selon l'exemple donné. Enfin on retire le dispositif.A linear knitting loom is supplied with calcium alginate fibers. We make a tabular knit in jersey whose diameter is substantially equal to that of the pin of the pliers. We put the knit on a form whose material is non-stick, Tel (registered trademark) for example. dressed form of the knitted fabric in a bath containing a 3% aqueous solution of alginate ester in order to coat the knitted fabric. The excess solution is removed and then dried with hot air, at 45 ° C. example given Finally we remove the device.
L'alginate, formant la nappe textile et le matériau d'enduction, présente des propriétés intéressantes pour les sutures. Il facilite la cicatrisation tissulaire. Il confère aux dispositifs une bonne résistance mécanique pour renforcer la plaie suturée durant la cicatrisation. Au contact du sang l'alginate d'enduction se ramollit et se charge de liquide biologique. Il se répand sur toute la surface du tissu et enveloppe les agrafes en obturant tous les interstices de la nappe et les perforations en assurant ainsi l'étanchéité à l'air et aux liquides.The alginate, forming the textile web and the coating material, has interesting properties for sutures. It facilitates tissue healing. It gives the devices good mechanical resistance to strengthen the sutured wound during healing. On contact with blood, the coating alginate softens and becomes charged with biological fluid. It spreads over the entire surface of the fabric and envelops the staples, sealing all the web gaps and perforations, thus ensuring air and liquid tightness.
Le procédé décrit ci-dessus présente cependant l'inconvénient de ne pas prendre en compte suffisamment les réactivités chimiques des matériaux en présence, c'est à dire l'alginate de calcium du support et la solution d'alginate de propylène glycol (PGA) de l'enduction. En effet, il existe une incompatibilité de base entre ces deux espèces chimiques : Une fibre d'alginate de calcium se gélifie, se désagrège et se solubilise progressivement dans une solution de PGA jusqu'à disparaître. Même si on sèche rapidement le matériau après l'étape d'immersion, le produit réalisé est imparfait, il apparaît notamment fragilisé mécaniquement.The process described above however has the disadvantage of not taking sufficient account of the chemical reactivities of the materials present, ie the calcium alginate of the support and the propylene glycol alginate solution (PGA). coating. In fact, there is a basic incompatibility between these two chemical species: A calcium alginate fiber gels, disintegrates and gradually dissolves in a PGA solution until it disappears. Even if the material is dried quickly after the immersion step, the product produced is imperfect, it appears in particular mechanically weakened.
La présente invention a pour objet un procédé de fabrication d'un dispositif renfort de suture surmontant l'incompatibilité entre les matériaux et conduisant à un produit dont la résistance mécanique est suffisante pour absorber, sans céder, les efforts exercés par les agrafes ou les fils de sutures.The present invention relates to a method of manufacturing a suture reinforcement device overcoming the incompatibility between the materials and leading to a product whose mechanical strength is sufficient to absorb, without yielding, the forces exerted by the staples or the threads. sutures.
La présente invention a également pour objet la fabrication d'un renfort de suture qui lorsqu'il est mis au contact d'un liquide physiologique conduit à une solubilisation progressive de l'enduction.The present invention also relates to the manufacture of a suture reinforcement which when brought into contact with a physiological liquid leads to a progressive dissolution of the coating.
Le procédé conforme à l'invention dans lequel on réalise une nappe textile à partir d'un alginate de calcium, on enduit la nappe au moyen d'alginate de propylène glycol en solution et on sèche la nappe, est caractérisé par le fait que ledit alginate de calcium est de type guluronique et que le dit alginate de propylène glycol avec lequel la nappe est enduite présente un taux d' esterification supérieur à 70% et de préférence supérieur à 80%.The process according to the invention in which a textile web is produced from a calcium alginate, the web is coated with propylene glycol alginate in solution and the web is dried, is characterized in that said calcium alginate is of the guluronic type and the said propylene glycol alginate with which the web is coated has an esterification rate greater than 70% and preferably greater than 80%.
De préférence, l'enduction est réalisée par immersion, le temps d'immersion de la nappe dans la solution est inférieur à 1 minute et la concentration d'alginate de propylène glycol dans la dite solution est comprise entre 3 et 10%. La concentration est déterminée de manière à obtenir une viscosité de la solution comprise entre 8000 et 16000 ctp à 25°C.Preferably, the coating is carried out by immersion, the immersion time of the sheet in the solution is less than 1 minute and the concentration of propylene glycol alginate in said solution is between 3 and 10%. The concentration is determined so as to obtain a viscosity of the solution of between 8000 and 16000 ctp at 25 ° C.
Grâce à ce procédé, on parvient de manière surprenante à maîtriser l'incompatibilité entre les matériaux. Sans être lié par une interprétation, on sait qu'une fraction des groupements carboxyles est inactivée par P esterification. Ainsi suivant le taux d' esterification, le PGA a une capacité de fixation calcique plus ou moins importante (la chélation des divalents nécessite des carboxyles libres adjacents). En choisissant un taux d' esterification supérieur à 70 - 80% on réduit sa réactivité. Par ailleurs des essais de résistance au cours du temps de dispositifs à base d'alginate de calcium imprégnés de PGA, et immergés dans Peau déminéralisée d'une part dans un milieu physiologique d'autre part, ont montré la supériorité de l'alginate de calcium de type guluronique par rapport à l'alginate de type mannuronique. On a pu ainsi par une sélection des matériaux alliée à un procédé approprié parvenir à la réalisation d'un produit parfaitement adapté.Thanks to this process, we surprisingly manage to control the incompatibility between the materials. Without being bound by an interpretation, we know that a fraction of the carboxyl groups is inactivated by P esterification. Thus, depending on the rate of esterification, the PGA has a more or less significant calcium fixing capacity (the chelation of the divalent requires adjacent free carboxyls). By choosing an esterification rate greater than 70 - 80%, the reactivity is reduced. Furthermore, tests of resistance over time of devices based on calcium alginate impregnated with PGA, and immersed in demineralized water on the one hand in a physiological medium on the other hand, have shown the superiority of alginate of guluronic type calcium compared to mannuronic type alginate. It was thus possible by a selection of materials combined with an appropriate process to achieve the production of a perfectly adapted product.
On tire par ailleurs profit de cette incompatibilité car lorsque le renfort sec est remis en contact avec un fluide biologique tel que le sang, une sérosité ou une solution chirurgicale de rinçage, la couche d'enduction de PGA se solubilise progressivement. Elle entraîne une adhérence immédiate aux tissus. Elle induit une étanchéité rapide, en quelques minutes, de la nappe en engluant cette dernière dans une couche visqueuse de PGA. Elle entraîne une gélification progressive et lente, en quelques jours, de la nappe. Elle facilite ainsi la biodégradation de la nappe, en quelques mois, au site implanté.We also take advantage of this incompatibility because when the dry reinforcement is brought back into contact with a biological fluid such as blood, serosity or a surgical rinsing solution, the PGA coating layer gradually dissolves. It causes immediate adhesion to tissue. It induces a rapid sealing, in a few minutes, of the sheet by embedding the latter in a viscous layer of PGA. It causes a gradual and slow gelation, within a few days, of the water table. It thus facilitates the biodegradation of the water table, in a few months, at the implanted site.
Selon un mode de réalisation préféré, la solution d'alginate de propylène glycol (PGA) est mise préalablement en émulsion. On réduit par les bulles d'air la quantité d'alginate déposée, et les bulles ralentissent la pénétration du PGA dans la nappe.According to a preferred embodiment, the propylene glycol alginate solution (PGA) is emulsified beforehand. The quantity of alginate deposited is reduced by air bubbles, and the bubbles slow down the penetration of the PGA into the sheet.
Après enduction la nappe est égouttée puis séchée par de Pair sec à une température de 40°C à 50°C, de préférence 45°C, jusqu'à obtenir une teneur en eau résiduelle après séchage inférieure à 15%.After coating, the sheet is drained and then dried with dry air at a temperature of 40 ° C. to 50 ° C., preferably 45 ° C., until a residual water content of less than 15% is obtained after drying.
On décrit ci-après le procédé plus en détail, appliqué à la fabrication de gaines de renfort de suture.The method is described below in more detail, applied to the manufacture of suture reinforcement sheaths.
On a fabriqué au préalable du fil d'alginate de calcium de façon conventionnelle. Le titre du fil est choisi entre 100 et 160 dTex. Conformément à une caractéristique de l'invention l'alginate est de type guluronique. Le rapport molaire entre les deux monomères de base : acide mannuronique M et acide guluronique G est choisi tel que M/G < 1# On réalise un tricot avec le fil sur une tricoteuse circulaire. La maille est un jersey bloqué de type « locked stitches » avec une jauge 32. Elle permet d'obtenir un tricot à maille serrée lorsque le fil est fin, comme ici. Le diamètre de la gaine est déterminé en fonction du type de pince auquel elle est destinée.Calcium alginate wire was previously produced in a conventional manner. The wire title is chosen between 100 and 160 dTex. According to a characteristic of the invention, the alginate is of the guluronic type. The molar ratio between the two basic monomers: mannuronic acid M and guluronic acid G is chosen such that M / G <1 # We knit with the thread on a circular knitter. The mesh is a locked jersey of the “locked stitches” type with a gauge 32. It allows to obtain a knitted fabric with a tight mesh when the thread is fine, as here. The diameter of the sheath is determined according to the type of clamp for which it is intended.
On enfile, déroule et coupe la gaine sur une forme en matériau anti-adhésif tel que le Téflon (marque déposée) à section polygonale correspondant à celle des branches de la pince.The sheath is put on, unrolled and cut on a form of non-stick material such as Teflon (registered trademark) with a polygonal section corresponding to that of the branches of the clamp.
On immerge l'ensemble dans une solution de PGA pendant un temps déterminé, inférieur à une minute.The whole is immersed in a PGA solution for a determined time, less than one minute.
Conformément à une autre caractéristique de l'invention, le taux d' esterification du PGA sélectionné est élevé. 11 est de préférence supérieur ou égal à 80%. Par exemple, on a sélectionné le produit commercialisé sous le nom Protanal ester L-25 A H par la société FMC. Le produit est obtenu à partir d'algues. Son degré d' esterification est compris entre 80 et 90%.According to another characteristic of the invention, the rate of esterification of the selected PGA is high. 11 is preferably greater than or equal to 80%. For example, the product sold under the name Protanal ester L-25 A H by the company FMC was selected. The product is obtained from seaweed. Its degree of esterification is between 80 and 90%.
De préférence, la concentration de la solution de PGA est comprise entre 3 et 10 % en fonction de la viscosité qui est elle-même comprise entre 8000 et 16000 ctp à 25°C. On a préparé ici une solution à 5% avec une viscosité d'environ 12000 ctp.Preferably, the concentration of the PGA solution is between 3 and 10% depending on the viscosity which is itself between 8000 and 16000 ctp at 25 ° C. A 5% solution was prepared here with a viscosity of about 12,000 ctp.
De préférence encore, on a formé une émulsion de la solution en incorporant de Pair mécaniquement dans un émulsionneur. La mousse présente l'avantage par ses bulles de réduire les zones de contact avec la matière constituant le tricot et de ralentir la pénétration de la solution au sein du tricot.More preferably, an emulsion of the solution was formed by mechanically incorporating air into an emulsifier. The foam has the advantage by its bubbles of reducing the contact zones with the material constituting the knitted fabric and of slowing down the penetration of the solution within the knitted fabric.
De façon optimale, après enduction, le tricot présente une partie interne d'alginate de calcium et une partie externe de PGA.Optimally, after coating, the knitted fabric has an internal part of calcium alginate and an external part of PGA.
On retire la forme de la solution et on laisse égoutter quelques instants.We remove the shape of the solution and let it drain for a few moments.
On procède ensuite au séchage de la gaine. Celui-ci doit satisfaire à une contrainte de rapidité pour réduire l'effet déstructurant du PGA sur le tricot. En effet une fois sec le PGA est compatible avec l'alginate de calcium. La température doit aussi être modérée pour éviter de détruire le PGA. Si la solution est sous la forme d'une mousse le séchage sous vide est à éviter.The sheath is then dried. This must satisfy a speed constraint to reduce the destructuring effect of PGA on knitting. In fact, once dry, the PGA is compatible with calcium alginate. The temperature should also be moderate to avoid destroying the PGA. If the solution is in the form of a foam, vacuum drying should be avoided.
On a procédé au séchage par balayage d'air sec à 45 °C. On a utilisé un système fourni par la société JVTUNTERS qui fonctionne au Silicagel (marque déposée) et délivre un débit d'air de 700 m3 /h à une hygrométrie de 5 à 10% pour une température entre 40 et 45°C.Drying was carried out by sweeping dry air at 45 ° C. We used a system supplied by the company JVTUNTERS which works with Silicagel (registered trademark) and delivers an air flow of 700 m 3 / h at a hygrometry of 5 to 10% for a temperature between 40 and 45 ° C.
Un cycle de séchage en enceinte de 0,5 m3 permet de traiter 7000 cm2 à 14000 cm2 , en fonction des formats . 14000 cm2 renfermant 2,3 litres d'eau, il faut 34,5 minutes pour amener l'échantillon à une teneur en eau résiduelle inférieure à 15% dans le produit fini. Le sécheur utilisé possède une capacité de 21 d'eau évaporée en 30' à une température de 45°C.A drying cycle in a 0.5 m 3 enclosure makes it possible to process 7000 cm 2 to 14000 cm 2 , depending on the formats. 14000 cm 2 containing 2.3 liters of water, it takes 34.5 minutes to bring the sample to a residual water content of less than 15% in the finished product. The dryer used has a capacity of 21 of water evaporated in 30 'at a temperature of 45 ° C.
Le produit, une fois séché, est démoulé. Pour rendre cette opération plus facile, on soumet la forme à un choc thermique, de 10 minutes à -25°C par exemple.The product, once dried, is demolded. To make this operation easier, the form is subjected to a thermal shock, for 10 minutes at -25 ° C. for example.
Enfin on découpe les gaines traitées à la longueur d'utilisation adaptée aux broches des pinces de suture.Finally, the treated sheaths are cut to the length of use adapted to the pins of the suture forceps.
On a réalisé ainsi un produit qui à l'analyse présente les caractéristiques suivantesA product was thus produced which, when analyzed, has the following characteristics
Grammage tricot 8-9 mg/cm2 Grammage enduction 3,5 - 4,5 mg/cm2 Knitting weight 8-9 mg / cm 2 Coating weight 3.5 - 4.5 mg / cm 2
Sodium <= 5%Sodium <= 5%
Dosage de l'alginate de calcium > 95%Calcium alginate dosage> 95%
Teneur en eau <15%Water content <15%
Pour montrer l'intérêt de l'emploi d'un alginate de type guluronique dans cette application, on a procédé à une étude comparative de résistance au cours du temps de renforts de suture pulmonaire après immersion en eau déminéralisée d'une part, en milieu physiologique d'autre part (sérum physiologique à 0,9%.To show the advantage of using a guluronic alginate in this application, a comparative study of resistance over time of pulmonary suture reinforcements was carried out after immersion in demineralized water on the one hand, in the middle. physiological on the other hand (physiological serum at 0.9%.
Les produits étaient des renforts à base d'alginate de calcium de type mannuronique (M) et guluronique (G) imprégné de PGA. On a immergé des échantillons simultanément dans des béchers contenant 40ml d'eau déminéralisée et dans des béchers contenant 20ml de NaCl à 0,9% * On a observé à différents temps de contact l'aspect des échantillons et évalué selon une échelle de 0 à 4, 0 étant la résistance faible et 4 une résistance forte.The products were reinforcements based on mannuronic (M) and guluronic (G) calcium alginate impregnated with PGA. Samples were immersed simultaneously in beakers containing 40ml of deionized water and in beakers containing 20ml of 0.9% NaCl * The appearance of the samples was observed at different contact times and evaluated on a scale of 0 to 4, 0 being the weak resistance and 4 being the strong resistance.
Dans l'eau déminéraliséIn demineralized water
Figure imgf000007_0001
Figure imgf000007_0001
Figure imgf000007_0002
Figure imgf000007_0002
Dans les deux cas, le renfort à base d'alginate de type M/G <1 possède une plus grande résistance à la déstructuration au cours du temps que le renfort à base d'alginate de calcium de type M G>1. In both cases, the reinforcement based on alginate type M / G <1 has greater resistance to destructuring over time than the reinforcement based on calcium alginate type M G> 1.

Claims

Revendicationsclaims
1) Procédé de fabrication d'un dispositif renfort de suture selon lequel on fabrique une nappe textile à partir d'un alginate de calcium, on enduit la nappe au moyen d'alginate de propylène glycol en solution et on sèche la nappe, caractérisé par le fait que ledit alginate de calcium est de type guluronique et que le dit alginate de propylène glycol avec lequel la nappe est enduite présente un taux d' esterification supérieur à 70%, de préférence supérieur 80%. 2) Procédé selon la revendication précédente, dans lequel le temps d'immersion de la nappe avec la solution est inférieur à 1 minute. 3) Procédé selon l'une des revendications précédentes dans lequel la concentration d'alginate de propylène glycol dans la dite solution est comprise entre 3 et 10%. 4) Procédé selon la revendication précédente dont la viscosité de la solution est comprise entre 8000 et 16000 ctp à 25°C.1) Method for manufacturing a suture reinforcement device according to which a textile sheet is made from a calcium alginate, the sheet is coated with propylene glycol alginate in solution and the sheet is dried, characterized by the fact that said calcium alginate is of the guluronic type and that said propylene glycol alginate with which the web is coated has an esterification rate greater than 70%, preferably greater than 80%. 2) Method according to the preceding claim, wherein the immersion time of the sheet with the solution is less than 1 minute. 3) Method according to one of the preceding claims wherein the concentration of propylene glycol alginate in said solution is between 3 and 10%. 4) Method according to the preceding claim, the viscosity of the solution is between 8000 and 16000 ctp at 25 ° C.
5) Procédé selon l'une des revendications précédentes dans lequel la dite solution d'alginate de propylène glycol forme une émulsion.5) Method according to one of the preceding claims wherein said propylene glycol alginate solution forms an emulsion.
6) Procédé selon l'une des revendications précédentes dans lequel la nappe après enduction est égouttée puis séchée par de Pair sec à une température de 40°C à 50°C.6) Method according to one of the preceding claims wherein the sheet after coating is drained and then dried with dry pair at a temperature of 40 ° C to 50 ° C.
7) Procédé selon la revendication précédente dans lequel air sec est à une hygrométrie comprise entre 5 et 10%.7) Method according to the preceding claim wherein the dry air is at a humidity between 5 and 10%.
8) Procédé selon l'une des revendications 6 et 7 dans lequel la teneur en eau résiduelle après séchage est inférieure à 15%.8) Method according to one of claims 6 and 7 wherein the residual water content after drying is less than 15%.
9) Procédé selon l'une des revendications précédentes dans lequel la nappe étant réalisée sous la forme d'une gaine, elle est montée avant enduction, sur une forme constituée en un matériau antiadhésif.9) Method according to one of the preceding claims wherein the web being produced in the form of a sheath, it is mounted before coating, on a form made of a non-stick material.
10) Procédé selon la revendication précédente dont une fois les gaines séchées, on fait subir à l'ensemble un choc thermique de rétraction de la forme et on retire la gaine. 10) Method according to the preceding claim which once the sheaths dried, the assembly is subjected to a thermal shock of shrinking the shape and the sheath is removed.
PCT/FR2004/000160 2003-01-27 2004-01-23 Method for the production of a suture reinforcement device WO2004075942A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR03/00856 2003-01-27
FR0300856A FR2850281A1 (en) 2003-01-27 2003-01-27 Production of a suture-reinforcing device comprises coating a guluronic-type calcium alginate textile material with a solution of propylene glycol alginate with a high degree of esterification

Publications (1)

Publication Number Publication Date
WO2004075942A1 true WO2004075942A1 (en) 2004-09-10

Family

ID=32669234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/000160 WO2004075942A1 (en) 2003-01-27 2004-01-23 Method for the production of a suture reinforcement device

Country Status (2)

Country Link
FR (1) FR2850281A1 (en)
WO (1) WO2004075942A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462963A1 (en) * 2010-12-08 2012-06-13 Les Laboratoires Brothier Method for manufacturing a medical reinforcement device

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8998059B2 (en) 2011-08-01 2015-04-07 Ethicon Endo-Surgery, Inc. Adjunct therapy device having driver with cavity for hemostatic agent
US9492170B2 (en) 2011-08-10 2016-11-15 Ethicon Endo-Surgery, Inc. Device for applying adjunct in endoscopic procedure
US8998060B2 (en) 2011-09-13 2015-04-07 Ethicon Endo-Surgery, Inc. Resistive heated surgical staple cartridge with phase change sealant
US9101359B2 (en) 2011-09-13 2015-08-11 Ethicon Endo-Surgery, Inc. Surgical staple cartridge with self-dispensing staple buttress
US9999408B2 (en) 2011-09-14 2018-06-19 Ethicon Endo-Surgery, Inc. Surgical instrument with fluid fillable buttress
US9254180B2 (en) 2011-09-15 2016-02-09 Ethicon Endo-Surgery, Inc. Surgical instrument with staple reinforcement clip
US8814025B2 (en) 2011-09-15 2014-08-26 Ethicon Endo-Surgery, Inc. Fibrin pad matrix with suspended heat activated beads of adhesive
US9125649B2 (en) 2011-09-15 2015-09-08 Ethicon Endo-Surgery, Inc. Surgical instrument with filled staple
US9393018B2 (en) 2011-09-22 2016-07-19 Ethicon Endo-Surgery, Inc. Surgical staple assembly with hemostatic feature
US9198644B2 (en) 2011-09-22 2015-12-01 Ethicon Endo-Surgery, Inc. Anvil cartridge for surgical fastening device
US8985429B2 (en) 2011-09-23 2015-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with adjunct material application feature
US8899464B2 (en) 2011-10-03 2014-12-02 Ethicon Endo-Surgery, Inc. Attachment of surgical staple buttress to cartridge
US9089326B2 (en) 2011-10-07 2015-07-28 Ethicon Endo-Surgery, Inc. Dual staple cartridge for surgical stapler

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0251905A2 (en) * 1986-06-30 1988-01-07 FIDIA S.p.A. Esters of alginic acid
EP0613693A1 (en) * 1993-03-03 1994-09-07 JOHNSON &amp; JOHNSON MEDICAL, INC. Swellable wound dressing materials
US5470576A (en) * 1992-06-08 1995-11-28 The Kendall Company Process for preparing the alginate-containing wound dressing
WO1999055397A1 (en) * 1998-04-29 1999-11-04 Fabrice Thevenet Reinforcing implants for tissue sutures
FR2789885A1 (en) * 1999-02-19 2000-08-25 Brothier Lab Suture reinforcing material is made in form of sleeves of polysaccharide based fabric coated to make it impermeable to liquids

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0251905A2 (en) * 1986-06-30 1988-01-07 FIDIA S.p.A. Esters of alginic acid
US5470576A (en) * 1992-06-08 1995-11-28 The Kendall Company Process for preparing the alginate-containing wound dressing
EP0613693A1 (en) * 1993-03-03 1994-09-07 JOHNSON &amp; JOHNSON MEDICAL, INC. Swellable wound dressing materials
WO1999055397A1 (en) * 1998-04-29 1999-11-04 Fabrice Thevenet Reinforcing implants for tissue sutures
FR2789885A1 (en) * 1999-02-19 2000-08-25 Brothier Lab Suture reinforcing material is made in form of sleeves of polysaccharide based fabric coated to make it impermeable to liquids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462963A1 (en) * 2010-12-08 2012-06-13 Les Laboratoires Brothier Method for manufacturing a medical reinforcement device
FR2968565A1 (en) * 2010-12-08 2012-06-15 Brothier Lab METHOD FOR MANUFACTURING A MEDICAL DEVICE FOR REINFORCING

Also Published As

Publication number Publication date
FR2850281A1 (en) 2004-07-30

Similar Documents

Publication Publication Date Title
WO2004075942A1 (en) Method for the production of a suture reinforcement device
CA2772409C (en) Fabric comprising picots coated with a hydrosoluble material
CN103083717B (en) Based on the surgical repair goods of HPPE material
US20080034801A1 (en) Medical fibres &amp; fabrics
FR2485046A1 (en) COMPOSITE WIRE RETORS AND APPLICATIONS THEREOF
FR2921675A1 (en) HYALURONIC ACID FILAMENT AND PROCESS FOR OBTAINING SAME
CH642531A5 (en) TEXTILE SHEET MATERIAL FOR CARDIOVASCULAR AND PROSTHETIC IMPLANTS.
FR2778081A1 (en) REINFORCEMENT IMPLANTS FOR TISSUE SUTURES
KR20160022870A (en) Highly absorbent polysaccharide fiber and use thereof
EP2424579A1 (en) Novel collagen materials and methods for obtaining same
JP6878703B2 (en) Textile products with sealants or coatings and manufacturing methods
KR20150090135A (en) Endless fibres on the basis of hyaluronan selectively oxidized in the position 6 of the n-acetyl-d-glucosamine group, preparation and use thereof, threads, staples, yarns, fabrics made thereof and method for modifying the same
EP2288744B1 (en) Combination of chitosan film and hydrogel, and surgical uses thereof
EP3031477A1 (en) Non-adherent wound healing interface, associated pad and dressing
JP4085113B2 (en) Composite fiber
CA2655012C (en) Collagen tubes
JP7209268B2 (en) Adhesive sheet for living body
JPS63115554A (en) Artificial blood vessel excellent in pseudo-endothelium forming property
WO2015004404A1 (en) Canvas to be painted, based on plant fibres
FR2867073A1 (en) Use of a chitosane thread for the preparation of a device, which is implanted under the skin for a cosmetic use to modify the appearance of an individual
EP1558172A1 (en) Intermediate composite part for shaping reinforcing prostheses
EP2462963B1 (en) Method for manufacturing a medical reinforcement device
JPS58183169A (en) Absorbable suturing yarn and production thereof
RU41976U1 (en) Suture
JP2006094932A (en) Connective tissue restorative material and its production method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase